BioLineRx Ltd.

Regulatory Filings • May 15, 2014

_________ false

C001������� �� ��� ��"�2PublicBIOLINE RX LTD9253Corporation no: 513398750Stock Exchange/Market: NASDAQ-SC2271379����� 19 , ������� 91450 , ,Tel: 02-5489100 , 02-5489116 Fax: 02-5489101E.mail address: info@BioLineRx.comReported via MAGNA: 15/05/2014              Time of broadcast: 21:22 21:18:06

Reference: 2014-02-065520

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Amendment No. 1 on Form 20-F/A, being filed solely to amend Exhibit 4.35 originally filed with the corporation's Annual Report on Form 20-F on March 17, 2014.
20-F-A_2013_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 14/05/2014
- - -
Name of the Signatory: : Kotler Norman Harold , Position of Signatory in the reporting corporation: General Counsel & Company Secretary , Name of Employer Company: .
Hartum Telephone: 02-5489100 , Facsimile: 02-5489101 , E-mail: normank@biolinerx.com 1